Argimicin B is a natural product belonging to the class of compounds known as macrolides, which are characterized by their large lactone rings. It is derived from the fermentation of specific bacterial strains, particularly those in the genus Streptomyces. This compound exhibits notable antibacterial properties, making it of interest in pharmaceutical research for potential therapeutic applications. Argimicin B has a complex molecular structure that contributes to its biological activity, including the ability to inhibit bacterial protein synthesis. Its mechanism of action typically involves binding to the ribosomal subunit of bacteria, thereby disrupting their ability to produce essential proteins. Additionally, Argimicin B may possess antifungal and antiparasitic activities, further broadening its potential uses in medicine. As with many natural products, the extraction and purification processes are critical for obtaining this compound in a form suitable for research and development. Ongoing studies aim to explore its efficacy, safety, and potential applications in treating various infectious diseases.

Argimicin B

663910-32-5: Argimicin B is a natural product belonging to the class of compounds known as macrolides, which are characterized by their large lactone rings. It is derived from the fermentation of specific bacterial strains, particularly those in the genus Streptomyces. This compound exhibits notable antibacterial properties, making it of interest in pharmaceutical research for potential therapeutic applications. Argimicin B has a complex molecular structure that contributes to its biological activity, including the ability to inhibit bacterial protein synthesis. Its mechanism of action typically involves binding to the ribosomal subunit of bacteria, thereby disrupting their ability to produce essential proteins. Additionally, Argimicin B may possess antifungal and antiparasitic activities, further broadening its potential uses in medicine. As with many natural products, the extraction and purification processes are critical for obtaining this compound in a form suitable for research and development. Ongoing studies aim to explore its efficacy, safety, and potential applications in treating various infectious diseases.

<p>Argimicin B is an antibiotic isolated from Sphingomonas sp. It exhibits algicidal activity against various harmful cyanobacteria, with a minimum inhibitory concentration (MIC) at the low micromolar level.</p>

CAS 663910-32-5

Argimicin B

Argimicin B

Ref: TM-TN9152